Registry for Proton Beam Radiation Therapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02040467 |
Recruitment Status :
Recruiting
First Posted : January 20, 2014
Last Update Posted : October 28, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Carcinoma |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 3200 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 10 Years |
Official Title: | Registry for Proton Beam Radiation Therapy |
Actual Study Start Date : | December 18, 2013 |
Estimated Primary Completion Date : | January 31, 2024 |
Estimated Study Completion Date : | January 31, 2024 |
- Treatment-specific data for all patients receiving proton beam radiation therapy [ Time Frame: 10 years ]Treatment-specific data collection record for all patients receiving proton beam radiation therapy

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
-Any patient receiving proton beam therapy is eligible for enrollment to this registry (regardless of diagnosis, age, other concurrent therapies, etc.) provided s/he consents to participate.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02040467
Contact: Jeff Michalski, M.D. | 314-362-8566 | jmichalski@wustl.edu |
United States, Florida | |
UF Health Cancer Center at Orlando Health | Recruiting |
Orlando, Florida, United States, 32806 | |
Contact: Naren Ramakrishna, M.D. Ph.D. 321-841-8650 Naren.Ramakrishna@orlandohealth.com | |
Principal Investigator: Naren Ramakrishna, M.D., Ph.D. | |
United States, Georgia | |
Emory University | Withdrawn |
Atlanta, Georgia, United States, 30308 | |
United States, Missouri | |
Washington University School of Medicine | Recruiting |
Saint Louis, Missouri, United States, 63110 | |
Contact: Jeff Michalski, M.D. 314-362-8566 jmichalski@wustl.edu | |
Principal Investigator: Jeff Michalski, M.D. | |
United States, New Jersey | |
Rutgers University | Completed |
New Brunswick, New Jersey, United States, 08903 | |
United States, Ohio | |
Cincinnati Childrens Hospital Medical Center | Recruiting |
Cincinnati, Ohio, United States, 45229 | |
Contact: John Perentesis, M.D. 513-636-8241 john.perentesis@cchmc.org | |
Principal Investigator: John Perentesis, M.D. | |
University of Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45267 | |
Contact: John Breneman, M.D. 513-584-5327 brenemjc@ucmail.uc.edu | |
Principal Investigator: John Breneman, M.D. |
Principal Investigator: | Jeff Michalski, M.D. | Washington University School of Medicine |
Responsible Party: | Washington University School of Medicine |
ClinicalTrials.gov Identifier: | NCT02040467 |
Other Study ID Numbers: |
201209025 |
First Posted: | January 20, 2014 Key Record Dates |
Last Update Posted: | October 28, 2022 |
Last Verified: | October 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |